Ali Khademhosseini

Ali Khademhosseini, born on October thirtieth, nineteen seventy-five, is an accomplished Iranian-born Canadian-American engineer and entrepreneur. He has made significant strides in the fields of biomedical innovation and engineering, serving as the CEO of the Terasaki Institute for Biomedical Innovation in Los Angeles, California. His academic journey includes a prestigious multi-departmental professorship at the University of California, Los Angeles, where he held the Levi Knight Chair in Engineering and contributed to the departments of Bioengineering, Radiology, and Chemical and Biomolecular Engineering.

Before his tenure at UCLA, Khademhosseini was a faculty member at Harvard Medical School and played a vital role at the Wyss Institute for Biologically Inspired Engineering from two thousand five to two thousand seventeen. His expertise also led him to a brief yet impactful position at Amazon, where he worked on biomedical technology initiatives during a one-year transition between UCLA and the Terasaki Institute.

Khademhosseini's prolific research output includes approximately one thousand scientific articles, which have garnered over one hundred fifty-seven thousand citations. His h-index, a measure of his research impact, stands at two hundred five as of January two thousand twenty-six. His work encompasses various domains, including biomaterials, tissue engineering, microfluidics, and biofabrication, with notable contributions to the development of Gelatin Methacryloyl hydrogels and multi-organ-on-a-chip platforms.

In addition to his academic achievements, Khademhosseini is deeply engaged in technology translation and entrepreneurship. He has played a crucial role in developing commercial products within the biomedical sector, including surgical sealants, wearable sensors, and embolic materials, showcasing his commitment to advancing healthcare through innovative solutions.